2017 attendees included the following:

Senior Legal Counsel, Zymergen

Vice President, Global Intellectual Property, AstraZeneca

SVP Legal and Secretary,  Jounce Therapeutics

Senior Legal Counsel, Novartis

Senior Vice President, Legal Affairs, Relay Therapeutics

Patent Counsel, Seven Bridges Genomics

General Counsel, Ranarx

Senior Director of Dispute Resolution, Regeneron Pharmaceuticals

Senior Vice President & General Counsel, Catabasis Pharmaceuticals

Patent Practitioner, ImmunoGen

Senior Corporate Counsel, Sanofi

Senior Director Intellectual Property, Research & Development, ImmunoGen

Senior Counsel, AbbVie

Director of Intellectual Property, Jounce Therapeutics

Chief IP Counsel, Bioverativ

Head of Patent, Cell and Gene Therapies Unit, Novartis

VP, Patent Head Oncology & IP Site Head, Novartis

Vice President, Head of Intellectual Property, Ranarx

Vice President Licensing, IP & Legal Affairs, Pieris Pharmaceuticals

Senior Manager, Takeda Oncology

Principal Counsel, Head of Biologic Patents US, Sanofi

SVP, General Counsel, Karyopharm Therapeutics

NIBR Patents, Novartis

Associate Counsel, Karyopharm Therapeutics

VP - Head of Intellectual Property, Vedanta Bio Sciences

Vice President - Intellectual Property, Dicerna Pharmaceuticals

Senior Corporate Patent Counsel, MilliporeSigma

Senior Corporate Counsel, Global Intellectual Property, Sanofi

Senior Patent Agent, Regeneron Pharmaceuticals

Patent Attorney, Regeneron Pharmaceuticals

VP, Intellectual Property, Paratek Pharmaceuticals

Managing Partner, Berken IP

Partner, Powell Gilbert LLP

Managing Principal, Marks & Clerk

Partner, Powell Gilbert LLP

Partner, Dardi & Herbert

Partner, Zhongzi Law Office

Associate, Nutter McClennen & Fish LLP

Senior Partner, WHD IP Group

Partner, Smart & Biggar/Fetherstonhaugh

Senior Partner, WHD IP Group

Partner, Nutter McClennen & Fish LLP

Partner, Aird & McBurney LLP

Patent Attorney, Nutter McClennen & Fish LLP